EODData

OTCBB, IUGNF: Imugene Ltd

13 Jan 2026
LAST:

0.1920

CHANGE:
 0.05
OPEN:
0.2101
HIGH:
0.2101
ASK:
0.0000
VOLUME:
53.6K
CHG(%):
20.00
PREV:
0.2400
LOW:
0.1920
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Jan 260.21010.21010.19200.192053.6K
12 Jan 260.24000.24000.22800.24002.4K
09 Jan 260.24000.24000.23060.24003.8K
08 Jan 260.23000.23000.19130.19132.0K
06 Jan 260.24500.24500.22400.224243.9K
02 Jan 260.25530.27000.22520.27002.9K
31 Dec 250.25000.26000.25000.260060.2K
30 Dec 250.24920.27750.24920.260117.0K
29 Dec 250.22000.22000.22000.2200300
26 Dec 250.22220.22500.18000.225010.7K

PROFILE

Name:Imugene Ltd
About:Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA, a combination of genomic sequences from various vaccinia virus strains to generate potent virus in phase 1 clinical trial for mixed advanced solid tumours; and CF33 CD19 chimeric antigen receptor T cells therapies to target solid tumours in phase 1 study. The company also develops CF33 oncolytic virotherapy; HER-VAXX, a B-cell immunotherapy cancer vaccine completed phase 2 clinical trial to target metastatic gastric cancer; HERIZON, which is in Phase 1b/2 study for HER-Vaxx and chemotherapy; PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling in phase 2 clinical trial to target non-small cell lung cancer; and NeoPOLEM in phase 2 study for MSI-high colorectal cancer. Imugene Limited is headquartered in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:4-6 Bligh Street, Sydney, NSW, Australia, 2000
Website:https://www.imugene.com
FIGI:BBG000QBT987

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.2213.3%
MA10:0.2321.0%
MA20:0.2216.3%
MA50:0.2317.2%
MA100:0.184.2%
MA200:0.1086.0%
STO9:0.81 
STO14:0.81 
RSI14:48.65
WPR14:-99.11 
MTM14:-0.03
ROC14:-0.13 
ATR:0.03 
Week High:0.2527.6%
Week Low:0.190.4%
Month High:0.2844.5%
Month Low:0.1686.0%
Year High:0.3161.5%
Year Low:0.0010,566.7%
Volatility:70.16